Neuroscience and Neurological Disorders Research — CFDA 93.853

Neuroscience extramural dollars at $15.0 billion

USAspending.gov records $14,988,524,193.17 in obligations under CFDA 93.853. Eight thousand one hundred forty-six awards produce that stock. A simple average is about $1.84 million per award, slightly below the dollars-per-award ratio on aging (93.866) and cardiovascular (93.837) research in this batch, still in the multi-year project-grant band. The assistance-listing title is EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS. CFDA 93.853 is the join key.

The packet does not split the $15.0 billion between “neurosciences” and “neurological disorders.” Searchers who want only one of those phrases will not find a percentage in these four facts. Awards land here if tagged 93.853.

USAspending.gov is the source for $14,988,524,193.17 in obligations on CFDA 93.853, with 8,146 awards, 667 recipients, and 52 states. A campus that quotes a larger neuroscience total may be mixing other research CFDAs into one headline. This write-up does not. The $15.0 billion is the 93.853 obligation stock, not a published split between neurosciences and neurological disorders, and not laboratory outlays.

Six hundred sixty-seven recipients, 52 states

Six hundred sixty-seven recipients share 8,146 awards, or about 12 award records per recipient on average. Splitting $15.0 billion evenly would assign about $22.5 million per recipient. Large medical centers often hold many concurrent 93.853 awards; the extract reports the count, not a concentration index.

Fifty-two states in the geographic count describe nationwide coding in the USAspending state field. It does not mean research dollars track stroke or Alzheimer’s prevalence by state. Place-of-performance follows coded recipient locations, which can cluster in research metros.

Research CFDA, not a treatment census

CFDA 93.853 sizes extramural research assistance tagged to this listing. It does not count surgeries, prescriptions, or patients treated. Award count (8,146) is a count of assistance records, including supplements and renewals as stored. Citing 8,146 as trials completed would over-read the packet.

Diabetes/kidney (93.847), cardiovascular (93.837), and aging (93.866) research remain separate CFDAs. Adding them to 93.853 would invent a combined biomedical-research total this packet does not contain.

Obligations versus laboratory draws

The $15.0 billion is an obligation total from USAspending.gov. Outlays on extramural research usually trail as institutions draw over a project period. This page does not publish a spend-down. Closeout deobligations reduce the stock; competing renewals increase it.

When an institution’s ledger disagrees with USAspending, filter to CFDA 93.853 and to obligations rather than expenditures. Those two checks remove most false conflicts.

Opening the 93.853 table

The neuroscience and neurological-disorders research program page overlays these aggregates. The all-programs index ranks 93.853 among other assistance listings. Agency pages show awarding-agency rollups that may include this CFDA among other research listings. For 93.853 only, use the program page.

CFDA 93.853 stores $14,988,524,193.17 in obligations on 8,146 awards and 667 recipients, with a 52-state geographic count. Neurosciences and neurological disorders share the title; they do not share a published split of the $15.0 billion in these four facts. About $1.84 million per award is a multi-year project-grant ratio. Eight thousand one hundred forty-six is not trials completed. Fifty-two geographic labels do not track disease prevalence.

Patient counts, prescriptions, and laboratory outlays are outside the packet. Other disease-research listings remain separate CFDA rows. The program page overlays 93.853. Source: USAspending.gov assistance awards.

Neuroscience extramural research as a stock

Extramural Research Programs in the Neurosciences and Neurological Disorders, CFDA 93.853, shows $14,988,524,193.17 in obligations, 8,146 awards, 667 recipients, and 52 states on USAspending.gov. About $1.84 million per award is slightly below the dollars-per-award ratio on some other research CFDAs in this batch, still in the multi-year project-grant band. The title pairs neurosciences with neurological disorders; the four facts do not split the $15.0 billion between those phrases.

Six hundred sixty-seven recipients against 8,146 awards is about 12 records per organization, the same many-awards-per-recipient pattern as other extramural files. Fifty-two states in the geographic count is nationwide coding in the USAspending state field. It does not allocate dollars by stroke or dementia prevalence. Place-of-performance follows coded recipient locations.

Do not add other disease-research listings into the $15.0 billion. Do not treat 8,146 awards as trials completed. Do not treat the stock as outlays. The program page overlays 93.853; the programs index ranks it; agency pages may include this CFDA among other research listings. Source: USAspending.gov assistance awards.

Questions

How much is obligated for neuroscience and neurological-disorder research?

USAspending.gov records $14,988,524,193.17 in obligations for CFDA 93.853. SpendingVault indexes 8,146 awards, 667 recipients, and 52 states. The figure is an obligation sum from assistance awards, not an outlay. The packet does not split the total between neurosciences and neurological disorders.

How many institutions receive CFDA 93.853 awards?

The extract lists 667 recipients against 8,146 awards, about 12 award records per recipient on a simple average. An even split of $15.0 billion would be about $22.5 million per recipient; actual portfolios are uneven. Names are on the program page.

Does 52 states mean funding follows neurological-disease rates?

No. Fifty-two states appear in the USAspending geographic count. That reports how many state labels are attached to 93.853 awards. It does not allocate dollars by disease prevalence. Place-of-performance often follows research institutions. CFDA 93.853’s $15.0 billion on 8,146 awards and 667 recipients is the USAspending obligation stock.

Is $15.0 billion already spent on neuroscience research?

Not necessarily. Obligations are commitments on assistance awards tagged 93.853. Outlays are payments as institutions draw. This page reports the obligation stock from USAspending.gov and does not publish cash-paid or remaining-balance figures. CFDA 93.853’s $15.0 billion on 8,146 awards and 667 recipients is the USAspending obligation stock.